Salem ME, Puccini A, Mauer E, André T, George TJ, Tabernero J, Sinicrope FA, Tie J, Kopetz S, Van Cutsem E, Lonardi S, Overman MJ, Foureau D. Impact of RAS/BRAF V600E mutations on the tumor immune microenvironment in mismatch repair deficient /microsatellite instability colorectal cancers.Clinical Cancer Research. 2025;:10.1158/1078-0432.ccr-25-2160
McLachlan S-A, Singh M, Hayes T, Lundy J, Wong ZW, Chong G, Saqib A, Steel S, Aghmesheh M, Begbie S, Roohullah A, Beale P, Ng W, Diakos C, Srivastav R, Rai S, Wong M, Karikios D, Barnett M, Lum C, Underhill C, Poursoltan P, Karki B, Karapetis C, Price T, Khattak A, Wuttke M, Karanth N, Jeffery M, Yelamanchili R, Batra A, Roitman D, Gotfrit J, Mussawar I, Kassam S, Goffin J, Rask S, Hubay S, Chen E, Samimi S, Martel S, Zurawska U, Wong R, Sideris L, Tang P, McGhie J, Arif S, Ahmed S, Michael J, Shim K, Babak S, Armstrong D, Burkes R, Kavan P. Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial. Nature Medicine. 2025;:10.1038/s41591-025-04030-w
Wonglhow J, Wong H-L, Michael M, Heriot A, Guerra G, Mitchell C, Tie J. Survival Outcomes and Prognostic Factors in Metastatic Unresectable Appendiceal Adenocarcinoma Treated with Palliative Systemic Chemotherapy: A 10-Year Retrospective Analysis from Australia. Cancers. 2025;17(20):10.3390/cancers17203297
Zaman FY, Orchard SG, Polekhina G, Gibbs P, Bernstein WB, Macrae F, Tie J, Millar J, Gately L, Rodríguez LM, van Londen GJ, Mar V, Hiscutt E, Adler N, Kent A, Ong WL, Haydon A, Warner E, Chan AT, Zalcberg J. Association of non-steroidal anti-inflammatory medications and aspirin with colorectal cancer incidence in older adults. Journal of the National Cancer Institute. 2025;117(9):10.1093/jnci/djaf145
Hitchen N, Wong H-L, Wong R, Shapiro J, Burge M, Nott L, Lee B, Lim SH, Wong SF, Caird S, Wong V, Rainey N, Khattak A, Mandaliya H, Hayes T, Torres J, Jalali A, Campbell A, Gibbs P, Tie J. Real-world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: the COALA project. ESMO Real World Data and Digital Oncology. 2025;9:10.1016/j.esmorw.2025.100178
Curtis SD, Panda S, Li A, Xu H, Bai Y, Ogihara I, O’Reilly E, Wang Y, Dobbyn L, Popoli M, Ptak J, Nehme N, Silliman N, Tie J, Gibbs P, Ho-Pham LT, Tran BNH, Tran TS, Nguyen TV, Irajizad E, Goggins M, Wolfgang CL, Wang T-L, Shih I-M, Fader A, Lennon AM, Hruban RH, Bettegowda C, Gilbert L, Kinzler KW, Papadopoulos N, Vogelstein B, Vogelstein JT, Douville C. Minimizing and quantifying uncertainty in AI-informed decisions: Applications in medicine. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(34):10.1073/pnas.2424203122
Curtis SD, Liu T, Bai Y, Wang Y, Panda S, Li A, Xu H, O’Reilly E, Dobbyn L, Popoli M, Ptak J, Silliman N, Thoburn C, Tie J, Gibbs P, Ho-Pham LT, Tran BNH, Tran TS, Nguyen TV, Konig MF, Petri M, Rosen A, Mecoli CA, Shah AA, Mulder F, van Es N, Bettegowda C, Kinzler KW, Papadopoulos N, Vogelstein JT, Vogelstein B, Douville C, Klok FA, Beyer-Westendorf J, Jara-Palomares L, Ageno W, Peters MJL, Delluc A, Best M, Guman N, Otten H-M, Mulder F, van Es N. Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases. Proceedings of the National Academy of Sciences of the United States of America. 2025;122(34):10.1073/pnas.2426890122
Michael M, Wong R, Gill S, Strickland AH, Pavlakis N, Shapiro JD, Link E, Farrell M, Ngan SY, Tie J, Heriot AG, Goldstein D, Mitchell C, Roth S, Wilson K, Mui M, Ramsay RG, Segelov E. The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.Clinical Cancer Research. 2025;31(16):10.1158/1078-0432.ccr-25-0705
Allan Z, Wang Y, Tie J, Tebbutt N, Clemons N, Papadolpoulos N, Kinzler K, Vogelstein B, Liu DSH. 091. MULTI-OMICS EVALUATION OF PERITONEAL FLUID IN GASTROESOPHAGEAL CANCER: RESULTS FROM INTERIM ANALYSIS. Diseases of the Esophagus. 2025;38(Supplement_1):10.1093/dote/doaf061.006
Desmond B, Alukaidey L, Allan Z, Cabalag C, Clemons NJ, Michael M, Tie J, Tebbutt N, Duong CP, Liu DS. Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic review. Surgical Oncology. 2025;61:10.1016/j.suronc.2025.102237
